ZENAS BIOPHARMA
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients. The company is headquartered in Florida, USA.
ZENAS BIOPHARMA
Social Links:
Industry:
Biopharma Health Care Pharmaceutical
Founded:
2020-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.zenasbio.com
Total Employee:
51+
Status:
Active
Total Funding:
318 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network Global Site Tag
Similar Organizations
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals is a biopharmaceutical company that focuses on developing innovative therapeutic treatments.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Endourage
Endourage is a pharmaceutical company that focuses on developing indication-specific therapeutics for clinical use.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Longitude Capital
Longitude Capital investment in Series C - Zenas BioPharma
Superstring Capital
Superstring Capital investment in Series C - Zenas BioPharma
Enavate Sciences
Enavate Sciences investment in Series C - Zenas BioPharma
Fairmount Funds Management
Fairmount Funds Management investment in Series C - Zenas BioPharma
Wellington Management
Wellington Management investment in Series C - Zenas BioPharma
Rock Springs Capital
Rock Springs Capital investment in Series C - Zenas BioPharma
Federated Hermes
Federated Hermes investment in Series C - Zenas BioPharma
Quan Capital
Quan Capital investment in Series C - Zenas BioPharma
Delos Capital
Delos Capital investment in Series C - Zenas BioPharma
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series C - Zenas BioPharma
Key Employee Changes
| Date | New article |
|---|---|
| 2024-07-01 | Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer |
| 2022-09-07 | Zenas BioPharma Appoints Simon Lowry, M.D. as Chief Medical Officer |
Official Site Inspections
http://www.zenasbio.com Semrush global rank: 1.89 M Semrush visits lastest month: 11.52 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Zenas BioPharma"
Who We Are - Zenas BioPharma
Ms. Chevalier also held several roles of increasing responsibility at Cubist Pharmaceuticals (acquired by Merck) in her 12-year tenure during which she gained experience across all …See details»
Zenas BioPharma Company Profile | Management and Employees …
Www.zenasbio.com Zenas BioPharma Profile and History Zenas BioPharma is a global biopharmaceutical company based in the USA and China committed to becoming a leader in …See details»
Life at Zenas - Zenas BioPharma
Ensuring a Thriving Global Culture. We are proud to be a global, diverse team with varying perspectives and experiences. Our ambitious vision necessitates a bold and empowered team …See details»
Zenas BioPharma - Crunchbase Company Profile & Funding
Zenas BioPharma announced that it had successfully raised $200 million in a Series C financing round to advance its mid and late-stage immunology-focused clinical development programs.See details»
Zenas BioPharma - Overview, News & Similar companies - ZoomInfo
Aug 18, 2024 www.zenasbio.com. Revenue $50 Million. Industry Drug Manufacturing & Research Pharmaceuticals Healthcare . Most Recent Scoops. Aug 19 2024. Open Position. …See details»
Zenas BioPharma Company Profile - Office Locations, Competitors …
Oct 22, 2024 Zenas BioPharma is a clinical-stage biopharmaceutical company that develops and commercializes transformative immunology-based therapies. Its product Obexelimab, is a …See details»
Zenas BioPharma - LinkedIn
Zenas BioPharma | 6,905 followers on LinkedIn. Enabling patients with autoimmune diseases to reimagine life | Zenas BioPharma (Nasdaq: ZBIO) is a clinical-stage global biopharmaceutical …See details»
Zenas BioPharma - The Org
Zenas BioPharma is a cross-border (China-USA-based) biopharmaceutical company committed to becoming a global leader in the development and delivery of immune-based therapies for …See details»
Zenas BioPharma Announces New Executive Leadership …
May 3, 2021 Hua Mu, MD, Ph.D. appointed President, CEO and Acting CMO Joe Farmer appointed CBO HONG KONG and BOSTON, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas …See details»
Zenas BioPharma - Overview, News & Similar companies - ZoomInfo
May 9, 2024 Zenas BioPharma contact info: Phone number: (857) 271-2954 Website: www.zenasbio.com What does Zenas BioPharma do? Zenas BioPharma is a global …See details»
Zenas BioPharma, Inc. (ZBIO) Company Profile & Overview - Stock …
Date Type Title; Dec 2, 2024: 8-K: Current Report : Nov 12, 2024: SC 13G: Statement of acquisition of beneficial ownership by individuals : Nov 12, 2024: 10-Q: Quarterly ReportSee details»
Contact Us - Zenas BioPharma
Contact Us. Corporate Headquarters 1000 Winter Street North Building Ste. 1200 Waltham, MA 02451. Get In Touch For investor- or media-related inquiries, please email [email protected]See details»
Zenas BioPharma Announces Strategic License and - GlobeNewswire
Sep 5, 2023 For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on Twitter at @ZenasBioPharma and LinkedIn. Investor and Media Contact : Joe …See details»
Zenas BioPharma Company Profile: Overview and Full News Analysis
News Summary Zenas BioPharma, Inc. (Zenas or the Company) announced the completion of its targeted enrollment for the Phase 3 INDIGO trial of its lead product candidate, obexelimab, for …See details»
Zenas BioPharma Launches as a Cross-Border - GlobeNewswire
Mar 23, 2021 For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on Twitter at @ZenasBioPharma and LinkedIn. Contacts. Investor Contact: Zenas BioPharma [email protected] ...See details»
Zenas BioPharma Secures $118 Million to Advance Its Broad …
Nov 7, 2022 For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on Twitter at @ZenasBioPharma and LinkedIn. About Obexelimab Obexelimab is an …See details»
Zenas BioPharma Secures $118 Million to Advance Its Broad …
Nov 9, 2022 Proceeds to fund global Phase 3 registration program for the company’s lead product candidate, Obexelimab, and support the clinical development of other pipeline …See details»
Zenas BioPharma Secures $118 Million to Advance Its Broad …
Nov 7, 2022 Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of …See details»
Zenas BioPharma Announces Strategic License and Collaboration …
Sep 5, 2023 Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab …See details»